SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
X	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Lux Ventures IV, L.P. (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol RECURSION PHARMACEUTICALS, INC. [ RXRX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) X Other (specify below) Former 10% Owner
	3. Date of Earliest Transaction (Month/Day/Year) 12/07/2021
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock	12/07/2021		J(1)		4,265,576	D	$0	13,021,519	D(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Lux Ventures IV, L.P. (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

1. Name and Address of Reporting Person* Lux Venture Partners IV, LLC (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

1. Name and Address of Reporting Person* Lux Co-Invest Opportunities, L.P. (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

1. Name and Address of Reporting Person* Lux Co-Invest Partners, LLC (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

1. Name and Address of Reporting Person* Hebert Peter (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

1. Name and Address of Reporting Person* Wolfe Josh (Last) (First) (Middle) C/O LUX CAPITAL MANAGEMENT 920 BROADWAY, 11TH FLOOR (Street) NEW YORK NY 10010 (City) (State) (Zip)

Explanation of Responses:

1. Pro rata distribution from Lux Ventures IV, L.P. to its partners. Lux Venture Partners IV, LLC is the general partner of Lux Ventures IV, L.P. and exercises voting and dispositive power over the shares noted herein held by Lux Ventures IV, L.P. Peter Hebert and Josh Wolfe are the individual managing members of Lux Venture Partners IV, LLC (the "Individual Lux Managers"). The Individual Lux Managers, as the sole managers of Lux Venture Partners IV, LLC, may be deemed to share voting and dispositive power for the shares noted herein held by Lux Ventures IV, L.P. Each of Lux Venture Partners IV, LLC and the Individual Lux Managers separately disclaim beneficial ownership over the shares noted herein except to the extent of their pecuniary interest therein.

	/s/ Peter Hebert, Manager, Lux Ventures IV, L.P.	12/09/2021
	/s/ Peter Hebert, Manager, Lux Venture Partners IV, LLC	12/09/2021
	/s/ Peter Hebert, Manager, Lux Co-Invest Opportunities, L.P.	12/09/2021
	/s/ Peter Hebert, Manager, Lux Co-Invest Partners, LLC	12/09/2021
	/s/ Peter Hebert	12/09/2021
	/s/ Josh Wolfe	12/09/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.